Medbio announces launch of additional, dedicated implant molding cell

Grand Rapids, Mich., August 1, 2017 - Medbio is pleased to announce the launch of an additional, dedicated implant molding cell, expanding on the company’s injection molding offerings. Continued growth in implantable component manufacturing for neurology and orthopedic OEMs has driven Medbio to expand its molding capacity in a class 7 clean room.

“We’re excited about our growth and the expanded capabilities in implantable components” says John Woodhouse, Dir. of Sales and Marketing for Medbio. We’ve increased our capacity to meet the growing needs of our customers, and we are better positioned to support the fast growing implant sector in the medical device industry.

Medbio has paired two 55-ton electric presses with Arburg’s micro molding modules to form the new implant molding cell. These two presses are contained in an ISO class 7 clean room. A number of top-performing operators are assigned to this cell and will receive specialized, ongoing training to ensure the highest-quality implants.

About Medbio, Inc.
Medbio ( is an ISO 13485:2003-certified medical contract manufacturer, specializing in clean room injection molding, assembly, and packaging, with clients based throughout the U.S., Europe, and Central America. Medbio is currently building products for the orthopedic, cardiovascular, ophthalmology, neurology, and biotechnology OEMs. Medbio has posted 11 years of growth, been honored as an Edward Lowe “Michigan 50 Companies to Watch,” and recognized in the Inc. 5000 list of fastest-growing private companies in America. Follow us on Facebook and LinkedIn.

# # #

John Woodhouse
(616) 245-0214 Ext. 113
Medbio, Inc.
[email protected]

View website